Search results
Results from the WOW.Com Content Network
Forest Laboratories and Adamas Pharmaceuticals Enter into Licensing Agreement for the Development and Commercialization of a Fixed Dosed Combination of Namenda XR® and Donepezil for Alzheimer's ...
Memantine/donepezil, sold under the brand name Namzaric among others, is a fixed dose combination medication used for the treatment of dementia of the Alzheimer's type. [1] It contains memantine, as the hydrochloride, a NMDA receptor antagonist; and donepezil as the hydrochloride, an acetylcholinesterase inhibitor. [1] It is taken by mouth. [1]
Memantine, sold under the brand name Namenda among others, is a medication used to slow the progression of moderate-to-severe Alzheimer's disease. [10] [11] [8] It is taken by mouth. [10] [8] Common side effects include headache, constipation, sleepiness, and dizziness. [10] [11] Severe side effects may include blood clots, psychosis, and heart ...
Donepezil, sold under the brand name Aricept among others, is a medication used to treat dementia of the Alzheimer's type. [3] [4] [8] It appears to result in a small benefit in mental function and ability to function. [9] Use, however, has not been shown to change the progression of the disease. [10] Treatment should be stopped if no benefit ...
Currently approved Alzheimer's treatments, such as Aricept and Namenda, generally try to keep brain cells from deteriorating. Aricept, which was originally developed by Eisai and Pfizer, ...
If it wasn't bad enough to lose 50% of its sales when Lexapro went off-patent in 2012, Forest Labs faces another stiff challenge when its current best seller, Namenda, loses patent protection in 2015.
Aricept – used to slow the progression of Alzheimer's disease; Ativan – a ... Memantine (Namenda) - treats Dementia and Alzheimer's. N
Just when you thought you knew it all, drug manufacturer Forest Laboratories (NYS: FRX) managed to squeeze blood out of a turnip again yesterday. With patent expirations looming large, Forest Labs ...